Abstract

EHMT2 is the main euchromatic H3K9 methyltransferase. Embryos with zygotic, or maternal mutation in the Ehmt2 gene exhibit variable developmental delay. To understand how EHMT2 prevents variable developmental delay we performed RNA sequencing of mutant and somite stage-matched normal embryos at 8.5–9.5 days of gestation. Using four-way comparisons between delayed and normal embryos we clarified what it takes to be normal and what it takes to develop. We identified differentially expressed genes, for example Hox genes that simply reflected the difference in developmental progression of wild type and the delayed mutant uterus-mate embryos. By comparing wild type and zygotic mutant embryos along the same developmental window we detected a role of EHMT2 in suppressing variation in the transcriptional switches. We identified transcription changes where precise switching during development occurred only in the normal but not in the mutant embryo. At the 6-somite stage, gastrulation-specific genes were not precisely switched off in the Ehmt2−/− zygotic mutant embryos, while genes involved in organ growth, connective tissue development, striated muscle development, muscle differentiation, and cartilage development were not precisely switched on. The Ehmt2mat−/+ maternal mutant embryos displayed high transcriptional variation consistent with their variable survival. Variable derepression of transcripts occurred dominantly in the maternally inherited allele. Transcription was normal in the parental haploinsufficient wild type embryos despite their delay, consistent with their good prospects. Global profiling of transposable elements revealed EHMT2 targeted DNA methylation and suppression at LTR repeats, mostly ERVKs. In Ehmt2−/− embryos, transcription over very long distances initiated from such misregulated ‘driver’ ERVK repeats, encompassing a multitude of misexpressed ‘passenger’ repeats. In summary, EHMT2 reduced transcriptional variation of developmental switch genes and developmentally switching repeat elements at the six-somite stage embryos. These findings establish EHMT2 as a suppressor of transcriptional and developmental variation at the transition between gastrulation and organ specification.

Highlights

  • The development of the mammalian embryo requires chromatin remodeling by the activity of epigenetic modifiers

  • We found that EHMT2 plays an important role in reducing transcriptional variation of genes and repeat elements at the six-somite stage embryos, which is consistent with its role in reducing variation in developmental delay

  • We examined the euchromatic histone H3 lysine9-methyltransferase 2 (Ehmt2)−/− homozygous (HOMO) embryos from the Ehmt2+/− X Ehmt2+/− parents (Fig 1A cross E) at different time points and found that they exhibited delayed development compared to their Ehmt2+/+ wild type (WT) and Ehmt2+/− heterozygous (HET) uterus mates (Fig 1B–1D)

Read more

Summary

Introduction

The development of the mammalian embryo requires chromatin remodeling by the activity of epigenetic modifiers. Zygotic mutation experiments (Fig 1A, cross E) reveal whether a factor is needed for development at the late preimplantation, postimplantation and fetal stages [16,17,18]. The dose of these epigenetic modifiers in the gametes (parental haploinsufficient) may have lasting effects on the offspring (Fig 1A, cross C versus cross A and cross D versus cross A). We designed a mouse study that allows measuring the effect of different deficiencies of the same epigenetic modifier on development and on the genome-wide transcription of the embryo. Maternal, and maternalzygotic mutant embryos in one comprehensive experiment together with mono-or biparental haploinsufficient wild type individuals and control wild type individuals from wild type parents (Fig 1A). We focused on the deficiencies of the euchromatic histone H3 lysine9-methyltransferase 2 (Ehmt2) gene

Methods
Results
Discussion
Conclusion
Full Text
Published version (Free)

Talk to us

Join us for a 30 min session where you can share your feedback and ask us any queries you have

Schedule a call